Haloom Rafehi
Impact in
-
- Congenital heart defects research
- Histone Deacetylase Inhibitors Research
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Rehabilitation top 10%
- Wound Healing and Treatments
Papers in
-
- Histone Deacetylase Inhibitors Research 8
- Epigenetics and DNA Methylation 5
- Protein Degradation and Inhibitors 4
- Genomics and Chromatin Dynamics 3
- Signaling Pathways in Disease 2
-
- Genetic Neurodegenerative Diseases 5
- Co-authors
- Assam El‐Osta (23 shared papers)Tom C. Karagiannis (13 shared papers)Katherine Ververis (5 shared papers)Mark Ziemann (14 shared papers)Christian Orlowski (2 shared papers)Antony Kaspi (5 shared papers)Xiao‐Jun Du (4 shared papers)Jenny Y. Y. Ooi (5 shared papers)
In The Last Decade
Haloom Rafehi
30 papers receiving 992 citations
Peers
Comparison fields: 5 of 104
- Molecular Biology 585
- Rehabilitation 57
- Cancer Research 110
- Biochemistry 40
- Endocrinology, Diabetes and Metabolism 100
Countries citing papers authored by Haloom Rafehi
This map shows the geographic impact of Haloom Rafehi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haloom Rafehi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haloom Rafehi more than expected).
Fields of papers citing papers by Haloom Rafehi
This network shows the impact of papers produced by Haloom Rafehi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haloom Rafehi. The network helps show where Haloom Rafehi may publish in the future.
Co-authors
The 25 scholars most cited alongside Haloom Rafehi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 185 | |
| 2 | 2011 | 173 | |
| 3 | 2015 | 110 | |
| 4 | 2014 | 66 | |
| 5 | 2011 | 53 | |
| 6 | 2010 | 49 | |
| 7 | 2018 | 46 | |
| 8 | 2012 | 44 | |
| 9 | 2011 | 37 | |
| 10 | 2011 | 35 | |
| 11 | 2017 | 29 | |
| 12 | 2012 | 29 | |
| 13 | 2020 | 22 | |
| 14 | 2017 | 19 | |
| 15 | 2017 | 15 | |
| 16 | 2016 | 14 | |
| 17 | 2016 | 11 | |
| 18 | 2016 | 9 | |
| 19 | 2023 | 8 | |
| 20 | 2015 | 8 |
About Haloom Rafehi
Haloom Rafehi is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience, Genetics, Cancer Research and Surgery, having authored 32 papers that have together received 1.0k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (8 papers), Epigenetics and DNA Methylation (5 papers), Genetic Neurodegenerative Diseases (5 papers), Protein Degradation and Inhibitors (4 papers), Genomics and Chromatin Dynamics (3 papers), Genetics and Neurodevelopmental Disorders (3 papers), Signaling Pathways in Disease (2 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Molecular Biology (585 citations), Rehabilitation (57 citations), Cancer Research (110 citations), Biochemistry (40 citations) and Endocrinology, Diabetes and Metabolism (100 citations). Haloom Rafehi has collaborated with scholars based in Australia, Hong Kong and China. Frequent co-authors include Assam El‐Osta, Tom C. Karagiannis, Katherine Ververis, Mark Ziemann, Christian Orlowski, Antony Kaspi, Xiao‐Jun Du, Jenny Y. Y. Ooi, Gregory A. Quaife-Ryan and James E. Hudson. Their work appears in journals such as Epigenetics, European Journal of Human Genetics, Journal of Visualized Experiments, Non-Coding RNA and Food & Function.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.